Skip to main content
Presentation
CKD outcomes in type 2 diabetes and moderate-to-severe CKD in Award-7: dulaglutide versus insulin glargine
American Society of Nephrology Kidney Week (2018)
  • Katherine Tuttle, Providence St. Joseph Health
  • M C Lakshmanan
  • B Rayner
  • A G Zimmermann
  • D B Wodward
  • F T Botros
Disciplines
Publication Date
April, 2018
Citation Information
Katherine Tuttle, M C Lakshmanan, B Rayner, A G Zimmermann, et al.. "CKD outcomes in type 2 diabetes and moderate-to-severe CKD in Award-7: dulaglutide versus insulin glargine" American Society of Nephrology Kidney Week (2018)
Available at: http://works.bepress.com/katherine-tuttle/148/